Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myelodysplastic syndromes | D009190 | — | D46 | 3 | 6 | 1 | — | — | 9 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 1 | 1 | 1 | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Myeloid leukemia acute | D015470 | — | C92.0 | 4 | 3 | — | — | — | 5 |
Primary myelofibrosis | D055728 | — | D47.4 | 2 | 1 | — | — | — | 2 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Leukemia | D007938 | — | C95 | 1 | — | — | — | — | 1 |
Hematologic diseases | D006402 | EFO_0005803 | D75.9 | 1 | — | — | — | — | 1 |
Myeloid leukemia | D007951 | — | C92 | 1 | — | — | — | — | 1 |
Preleukemia | D011289 | — | — | 1 | — | — | — | — | 1 |
Bone marrow diseases | D001855 | — | — | 1 | — | — | — | — | 1 |
Glioblastoma | D005909 | EFO_0000515 | — | 1 | — | — | — | — | 1 |
Drug common name | Sabatolimab |
INN | sabatolimab |
Description | Sabatolimab is an antibody pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4594575 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 3L7R886Y06 (ChemIDplus, GSRS) |